Voyager Therapeutics, Inc. reported its financial and operating results for the third quarter ended September 30, 2026. The company ended the quarter with cash, cash equivalents, and marketable securities of $132.1 million, which it expects will be sufficient to fund planned oper
Voyager Therapeutics Reports Third Quarter 2026 Financial Results and $132 Million Cash Position
Voyager Therapeutics, Inc. reported its financial and operating results for the third quarter ended September 30, 2026. ...
By Dhallo News · November 6, 2026 at 2:38 PM IST
Have feedback on this article?Report error or suggestion
